(1)
Chen, Z.-S.; Yang, D.-H. Selection of Optimal Therapeutic Modality for Early-Stage Extranodal Natural killer/T-Cell Lymphoma Patients under the Guidance of Single-Nucleotide Polymorphism Signature. Bosn J of Basic Med Sci 2021.